Publications by authors named "Severin Jacobi"

Claim this Profile
D
Deep Learning-Based MRI Volumetry for Living Kidney Donor Assessment: A New Tool for Predicting Post-Donation Renal Function.
Dominik Thomas Koch, Felix Oliver Hofmann, Dimitrios Trompoukis, Malte Schirren, Severin Jacobi

Clin Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRANSMIT: Utilizing discarded livers from donors with a history of cancer for patients lacking access to standard allocation - A compassionate use exploratory study.
Dominik Thomas Koch, Malte Schirren, Severin Jacobi, Christian Lange, Jens Werner

Contemp Clin Trials Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mono-HOPE Versus Dual-HOPE in Liver Transplantation: A Propensity Score-Matched Evaluation of Early Graft Outcome.
Dominik Thomas Koch, Micol Tamai, Malte Schirren, Moritz Drefs, Severin Jacobi

Transpl Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Hypothermic Oxygenated Machine Perfusion on Immune Cell Clearance in Liver Transplantation: Enhancing Graft Function and Post-Transplant Outcomes.
Dominik Thomas Koch, Malte Schirren, Severin Jacobi, Hanno Nieß, Bernhard Willibald Renz

J Clin Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothermic Oxygenated Machine Perfusion (HOPE) Prior to Liver Transplantation Mitigates Post-Reperfusion Syndrome and Perioperative Electrolyte Shifts.
Fabian Horné, Moritz Drefs, Malte Joachim Schirren, Dominik Thomas Koch, Ganildo Cepele, Severin Johannes Jacobi

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma.
Tilman L B Hölting, Florencia Cidre-Aranaz, Dana Matzek, Bastian Popper, Severin J Jacobi

Mol Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy.
Felicitas Rataj, Severin J Jacobi, Stefan Stoiber, Florian Asang, Justyna Ogonek

Br J Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice.
Gabriela Maria Wiedemann, Severin Johannes Jacobi, Michael Chaloupka, Angelina Krächan, Svetlana Hamm

Oncoimmunology· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis